心臟人工智慧监测和诊断市场—全球产业规模、份额、趋势、机会和预测，按产品、按类型、按应用、按最终用户、按地区和竞争细分，2020-2030 年

2024 年全球心臟人工智慧监测和诊断市场价值为 12.4 亿美元，预计到 2030 年将达到 21.1 亿美元，复合年增长率为 9.42%。这个市场正在经历快速发展，推动力来自心血管疾病负担的增加和对先进诊断技术日益增长的需求。人工智慧 (AI) 越来越多地被融入心臟护理中，透过对心电图、心臟成像和生物标记资料的高级分析，能够在早期准确地检测出心臟疾病。这些 AI 工具支持早期干预，减少诊断错误，并改善患者预后。随着远端监控和远距医疗的普及，人工智慧穿戴装置变得越来越普遍，可以提供对心臟健康的即时洞察和个人化护理。云端基础设施、资料整合能力和持续学习演算法的扩展进一步推动了整个生态系统的创新。市场预计将强劲成长，医疗保健提供者和科技公司正在合作提供可扩展、精确和可访问的心臟诊断。

关键市场驱动因素

心血管疾病发生率上升

主要市场挑战

数据可用性和品质

主要市场趋势

穿戴式装置和远端监控的兴起

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球心臟人工智慧监测与诊断市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（软体、硬体）
  • 按类型（心臟诊断{影像学、心电图诊断、其他诊断}、心臟监测）
  • 依应用（缺血性心臟病/冠状动脉疾病、心律不整、缺血性中风、其他）
  • 按最终使用者（医院、诊断中心、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美心臟人工智慧监测与诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲心臟人工智慧监测与诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太心臟人工智慧监测与诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲心臟人工智慧监测与诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲心臟人工智慧监测和诊断市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 13 章： 大环境分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• AliveCor Inc.
• Aidoc
• Boston Scientific Corporation
• Canon Inc.
• CathWorks
• Circle Cardiovascular Imaging Inc.
• General Electric Company
• HeartFlow, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips NV

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Cardiac AI Monitoring and Diagnostics Market was valued at USD 1.24 billion in 2024 and is projected to reach USD 2.11 billion by 2030, growing at a CAGR of 9.42%. This market is experiencing rapid evolution, driven by the rising burden of cardiovascular diseases and the growing demand for advanced diagnostic technologies. Artificial intelligence (AI) is increasingly being integrated into cardiac care, enabling early and accurate detection of heart conditions through advanced analysis of ECGs, cardiac imaging, and biomarker data. These AI tools support early intervention, reduce diagnostic errors, and improve patient outcomes. As remote monitoring and telemedicine adoption accelerate, AI-powered wearable devices are becoming more prevalent, offering real-time insights into heart health and personalized care. The expansion of cloud infrastructure, data integration capabilities, and continuous learning algorithms is further fueling innovation across the ecosystem. The market is set for robust growth, with healthcare providers and technology companies collaborating to deliver scalable, precise, and accessible cardiac diagnostics.

Key Market Drivers

Rise in Cardiovascular Diseases

The increasing global prevalence of cardiovascular diseases (CVDs) is a key driver of the Cardiac AI Monitoring and Diagnostics Market. Responsible for approximately 17.9 million deaths annually, CVDs remain the leading cause of mortality worldwide. Early detection and timely management are crucial, yet traditional methods often fail to identify asymptomatic or early-stage cardiac issues. AI-driven diagnostic tools offer enhanced accuracy by analyzing vast datasets-including ECGs, imaging, and lab results-to detect subtle indicators of disease. A 2024 study in The Lancet Digital Health reported over 90% diagnostic accuracy in identifying asymptomatic left ventricular dysfunction using AI-enhanced ECGs. This advanced capability allows clinicians to intervene earlier, improving patient outcomes and reducing healthcare burdens. As awareness grows and healthcare systems prioritize proactive management of heart disease, AI-enabled diagnostics are becoming an essential part of modern cardiology.

Key Market Challenges

Data Availability and Quality

One of the major challenges facing the Cardiac AI Monitoring and Diagnostics Market is the variability and fragmentation of cardiac health data. Data is sourced from diverse systems such as wearables, electronic health records, imaging tools, and clinical sensors, which often lack interoperability. This inconsistency hinders seamless integration and limits the formation of comprehensive datasets needed for effective AI model training. In addition, annotated or labeled cardiac datasets are often scarce, as producing them requires labor-intensive manual review by experts. Bias in data collection-due to uneven representation of demographics or conditions-can also affect model performance, leading to unreliable results or unequal care outcomes. Without standardization and centralized data sharing frameworks, the pace of AI development and deployment in cardiac diagnostics may be slowed, limiting the market's full potential.

Key Market Trends

Rise of Wearable and Remote Monitoring

The growing adoption of AI-powered wearable devices is transforming the way cardiac conditions are monitored and managed. These devices continuously track heart activity, gather vital data, and provide real-time feedback to patients and clinicians, enabling proactive care. Personalized cardiac care is also emerging as a key trend, with AI analyzing patient-specific data-such as genetics, lifestyle, and physiological indicators-to customize treatment strategies. AI is increasingly being applied to interpret ECGs, echocardiograms, and other imaging tools, aiding in the early detection of subtle cardiac anomalies. Additionally, AI is streamlining clinical trials by improving patient selection and predicting therapeutic outcomes. The widespread adoption of telemedicine following the COVID-19 pandemic has further propelled interest in AI-enabled diagnostic tools that support remote consultations. As these algorithms evolve with continuous learning from real-world data, their diagnostic precision and clinical utility are expected to increase, driving greater integration into standard cardiac care pathways.

Key Market Players

• AliveCor Inc.
• Aidoc
• Boston Scientific Corporation
• Canon Inc.
• CathWorks
• Circle Cardiovascular Imaging Inc.
• General Electric Company
• HeartFlow, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.

Report Scope:

In this report, the Global Cardiac AI Monitoring and Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cardiac AI Monitoring and Diagnostics Market, By Product:

• Software
• Hardware

Cardiac AI Monitoring and Diagnostics Market, By Type:

• Cardiac Diagnostics (Imaging, ECG-Based, Others)
• Cardiac Monitoring

Cardiac AI Monitoring and Diagnostics Market, By Application:

• Ischemic Heart Disease/CAD
• Cardiac Arrhythmias
• Ischemic Stroke
• Others

Cardiac AI Monitoring and Diagnostics Market, By End User:

• Hospitals
• Diagnostic Centers
• Other

Cardiac AI Monitoring and Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cardiac AI Monitoring and Diagnostics Market.

Available Customizations:

Global Cardiac AI Monitoring and Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cardiac AI Monitoring and Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Software, Hardware)
  • 5.2.2. By Type (Cardiac Diagnostics {Imaging, ECG-Based, Others}, Cardiac Monitoring)
  • 5.2.3. By Application (Ischemic Heart Disease/CAD, Cardiac Arrhythmias, Ischemic Stroke, Others)
  • 5.2.4. By End User (Hospitals, Diagnostics Centers, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Cardiac AI Monitoring and Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Cardiac AI Monitoring and Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Cardiac AI Monitoring and Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Cardiac AI Monitoring and Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Cardiac AI Monitoring and Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Cardiac AI Monitoring and Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Cardiac AI Monitoring and Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. AliveCor Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Aidoc
• 15.3. Boston Scientific Corporation
• 15.4. Canon Inc.
• 15.5. CathWorks
• 15.6. Circle Cardiovascular Imaging Inc.
• 15.7. General Electric Company
• 15.8. HeartFlow, Inc.
• 15.9. iRhythm Technologies, Inc.
• 15.10. Koninklijke Philips N.V.

16. Strategic Recommendations

17. About Us & Disclaimer